SHC
Sotera Health Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$18.73
−1.16%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$18.91
From 52W high−4.29%
Volume6.09M
Market cap$5.35B
P/E (TTM)32.7x
P/S (TTM)4.4x
Div yield—
Key dataSep 18, 2026
Open
$18.91
From 52W high
−4.29%
Volume
6.09M
Market cap
$5.35B
ValuationView details →
P/E (Fwd)
18.2x
EV/EBITDA
13.5x
P/E (TTM)
32.7x
RSI (14)
51.1
MomentumView details →
1D Return
−1.16%
YTD Return
+6.66%
SummaryUpdated Jun 1, 2026
Sotera Health Company (NASDAQ:SHC) is a mission-critical sterilization and laboratory testing services provider that went public in November 2020. Founded in 2017 and headquartered in Broadview Heights, Ohio, the company operates through three main business segments serving the medical device, pharmaceutical, and food industries. Sotera Health has achieved 19 consecutive years of revenue growth and plays an essential role in ensuring the safety and efficacy of medical products before they reach patients and consumers.
Similar companies
Latest newsMore news →
Bank of America Corp DE increased its stake in Sotera Health Company by 332.7% during the quarter, acquiring an additional 991,620 shares, according to a Form 13F filing.31d agoJames C. Neary resigned as Class I director of Sotera Health Co, effective August 13, 2026.38d agoSotera Health Co reported Q2 2026 financial results with revenue of $321.4 million, net income of $53.6 million, and diluted EPS of $0.19.46d ago